Skip to website navigation Skip to article navigation Skip to content

A page refresh occures when a subject is selected.

Skip article navigation.

UCB At a Glance

Our performance

Our performance

Despite the challenges created by the ongoing COVID-19 pandemic, UCB continues to grow our business in a sustainable way, achieving a strong financial performance in 2020, investing in research and development, and making progress on our commitments to society.

Performance data

   
 

2018

2019

2020

Financial Performance

   

Continuous growth

   

Revenue (€ million)

4 632

4 913

5 347

Adjusted  EBITDA/revenue ratio

30%

29%

27%

R&D expense/revenue ratio

25%

26%

29%

Extra-financial Performance

   

Value for Patients

   

# Assets in pipeline

10

7

12

Access performance index1

   

   Reimbursement for all patients within regulatory label

n/a

n/a

30%

   Reimbursement for some, but not all patients within regulatory label

n/a

n/a

54%

   No reimbursement, or reimbursement is pending

n/a

n/a

16%

Value for People

   

Health, safety and wellbeing index2

n/a

n/a

78.4%

Gender diversity

   

   % Female/male [whole company]

49%/51%

50%/50%

50%/50%

   % Female/male [executive level]

29%/71%

33%/67%

34%/66%

   % Female/male [board]

31%/69%

38%/62%

38%/62%

Value for Planet³

   

Absolute reduction in carbon emissions for operations we directly control⁴

-30%

-35%

-60%

Reduced waste generation

-24%

-32%

-38%

Reduced water withdrawal

-1%

-27%

-30%

    
  • 1 In 2020, we measured our access performance in 14 countries (Belgium, China, Denmark, Finland, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, the United Kingdom, and the United States [Medicaid, Medicare, and Commercial insurance]) for four products (Briviact®, Cimzia®, Evenity®, and Vimpat®. Scope of analysis and reporting will be increased in 2021.
  • 2 In 2020, UCB evolved our health, safety and wellbeing (HSWB) ambition and delivery model, including the launch of a new HSWB index that will provide us with an overarching view of our performance and impact. The baseline listed here will serve as a benchmark to measure the impact of all future HSWB programs or initiatives that will be rolled out starting in 2021.
  • 3 Environmental data is compared with our baseline year of 2015.
  • 4 On-going CO2 calculation for our indirect impact (purchase goods and services). Based on the amount spent and type of suppliers (services, raw material, accommodations, etc.) we apply a CO2 emissions factors (except for business travel, fleet, CMOs and sites’ energy where we use the actual fossil fuel consumption instead of spending). We have already started to assess about half of our suppliers on their carbon maturity (from “no calculation of footprint” to “commit to carbon neutrality”).

The financial and extra-financial data are reported for the period 1 January – 31 December. Financial data is reported semi-annually, and extra-financial data is reported annually. The last UCB Annual Integrated Report was published on February 20, 2020.